<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36680646</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7284</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of epidemiology</Title><ISOAbbreviation>Eur J Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Characterising patterns of COVID-19 and long COVID symptoms: evidence from nine UK longitudinal studies.</ArticleTitle><Pagination><StartPage>199</StartPage><EndPage>210</EndPage><MedlinePgn>199-210</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10654-022-00962-6</ELocationID><Abstract><AbstractText>Multiple studies across global populations have established the primary symptoms characterising Coronavirus Disease 2019 (COVID-19) and long COVID. However, as symptoms may also occur in the absence of COVID-19, a lack of appropriate controls has often meant that specificity of symptoms to acute COVID-19 or long COVID, and the extent and length of time for which they are elevated after COVID-19, could not be examined. We analysed individual symptom prevalences and characterised patterns of COVID-19 and long COVID symptoms across nine UK longitudinal studies, totalling over 42,000 participants. Conducting latent class analyses separately in three groups ('no COVID-19', 'COVID-19 in last 12&#xa0;weeks', 'COVID-19&#x2009;&gt;&#x2009;12&#xa0;weeks ago'), the data did not support the presence of more than two distinct symptom patterns, representing high and low symptom burden, in each group. Comparing the high symptom burden classes between the 'COVID-19 in last 12&#xa0;weeks' and 'no COVID-19' groups we identified symptoms characteristic of acute COVID-19, including loss of taste and smell, fatigue, cough, shortness of breath and muscle pains or aches. Comparing the high symptom burden classes between the 'COVID-19&#x2009;&gt;&#x2009;12&#xa0;weeks ago' and 'no COVID-19' groups we identified symptoms characteristic of long COVID, including fatigue, shortness of breath, muscle pain or aches, difficulty concentrating and chest tightness. The identified symptom patterns among individuals with COVID-19&#x2009;&gt;&#x2009;12&#xa0;weeks ago were strongly associated with self-reported length of time unable to function as normal due to COVID-19 symptoms, suggesting that the symptom pattern identified corresponds to long COVID. Building the evidence base regarding typical long COVID symptoms will improve diagnosis of this condition and the ability to elicit underlying biological mechanisms, leading to better patient access to treatment and services.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bowyer</LastName><ForeName>Ruth C E</ForeName><Initials>RCE</Initials><Identifier Source="ORCID">0000-0002-6941-8160</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Alan Turing Institute, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5960-4771</Identifier><AffiliationInfo><Affiliation>Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toms</LastName><ForeName>Renin</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6922-1448</Identifier><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Wellbeing, School of Health Sciences, Cardiff Metropolitan University, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-7906-6066</Identifier><AffiliationInfo><Affiliation>MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Bo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5337-6560</Identifier><AffiliationInfo><Affiliation>Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Ellen J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0003-2118-821X</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwong</LastName><ForeName>Alex S F</ForeName><Initials>ASF</Initials><Identifier Source="ORCID">0000-0003-1953-2771</Identifier><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Psychiatry, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Dylan M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-3825-2487</Identifier><AffiliationInfo><Affiliation>MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kibble</LastName><ForeName>Milla</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ploubidis</LastName><ForeName>George B</ForeName><Initials>GB</Initials><Identifier Source="ORCID">0000-0002-8198-5790</Identifier><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timpson</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-7141-9189</Identifier><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterne</LastName><ForeName>Jonathan A C</ForeName><Initials>JAC</Initials><Identifier Source="ORCID">0000-0001-8496-6053</Identifier><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Bristol Biomedical Research Centre, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK South West, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaturvedi</LastName><ForeName>Nishi</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6211-2775</Identifier><AffiliationInfo><Affiliation>MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steves</LastName><ForeName>Claire J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-4910-0489</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, School of Life Course and Population Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ageing and Health, Guy's and St Thomas' NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tilling</LastName><ForeName>Kate</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1010-8926</Identifier><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverwood</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-2744-1194</Identifier><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK. r.silverwood@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CONVALESCENCE Study</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>104036/Z/14/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>217065/Z/19/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>216767/Z/19/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P023444/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT212904/Z/18/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20030</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20051</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_15018</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00011/3</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>221574/Z/20/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G9815508</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/W021315/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00019/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CS/16/4/32482</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N024397/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>202802/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT101597MA</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Epidemiol</MedlineTA><NlmUniqueID>8508062</NlmUniqueID><ISSNLinking>0393-2990</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Clustering</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Longitudinal studies</Keyword><Keyword MajorTopicYN="N">Symptom patterns</Keyword></KeywordList><CoiStatement>NC serves and gets paid for sitting on data safety and monitoring committees for drug trials sponsored by AstraZeneca. CJS acts as a consultant for ZOE Ltd for design of ZOE health studies. All other authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36680646</ArticleId><ArticleId IdType="pmc">PMC9860244</ArticleId><ArticleId IdType="doi">10.1007/s10654-022-00962-6</ArticleId><ArticleId IdType="pii">10.1007/s10654-022-00962-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. 2022;37(5):539&#x2013;548. doi: 10.1007/s10654-022-00847-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) dashboard 2022. https://covid19.who.int/.</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D. Inflammation triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: molecular mechanisms and implications. Inflammation. 2021;44(1):13&#x2013;34. doi: 10.1007/s10753-020-01337-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-020-01337-3</ArticleId><ArticleId IdType="pmc">PMC7541099</ArticleId><ArticleId IdType="pubmed">33029758</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), Royal College of General Practitioners (RCGP). COVID-19 rapid guideline: managing the long-term effects of COVID-19. https://www.nice.org.uk/guidance/ng188/resources/covid19-rapid-guideline-managing-the-longterm-effects-of-covid19-pdf-51035515742. 2022.</Citation></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long covid. Soc Sci Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A, Iqbal K, Arshad Ali S, Azim D, Farid E, Baig MD, et al. The COVID-19 sequelae: a cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus. 2021;13(2):e13080-e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. medRxiv. 2021 doi: 10.1101/2021.06.28.21259452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among french adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182(1):19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Osikomaiya B, Erinoso O, Wright KO, Odusola AO, Thomas B, Adeyemi O, et al. &#x2018;Long COVID&#x2019;: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect Dis. 2021;21(1):304. doi: 10.1186/s12879-020-05716-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05716-x</ArticleId><ArticleId IdType="pmc">PMC7993075</ArticleId><ArticleId IdType="pubmed">33765941</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75(10):e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z, Ladhani SN. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med. 2021;27(7):1129&#x2013;1130. doi: 10.1038/s41591-021-01402-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01402-w</ArticleId><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study) Int J Epidemiol. 2006;35(1):34&#x2013;41. doi: 10.1093/ije/dyi183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyi183</ArticleId><ArticleId IdType="pubmed">16155052</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M, Goodman A, Peters A, Ploubidis GB, Sanchez A, Silverwood R, et al. COVID-19 survey in five national longitudinal studies: waves 1, 2 and 3 user guide (Version 3) London: UCL Centre for Longitudinal Studies and MRC Unit for Lifelong Health and Ageing; 2021.</Citation></Reference><Reference><Citation>Elliott J, Shepherd P. Cohort profile: 1970 British birth cohort (BCS70) Int J Epidemiol. 2006;35(4):836&#x2013;843. doi: 10.1093/ije/dyl174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyl174</ArticleId><ArticleId IdType="pubmed">16931528</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderwood L, Sanchez C. Next steps (formerly known as the Longitudinal study of young people in England) Open Health Data. 2016;4(1):e2.</Citation></Reference><Reference><Citation>Joshi H, Fitzsimons E. The Millennium cohort study: the making of a multi-purpose resource for social science and policy. Longitud Life Course Stud. 2016;7(4):409&#x2013;430. doi: 10.14301/llcs.v7i4.410.</Citation><ArticleIdList><ArticleId IdType="doi">10.14301/llcs.v7i4.410</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, et al. Cohort profile: the &#x2018;Children of the 90s&#x2019;&#x2014;the index offspring of the Avon Longitudinal study of parents and children. Int J Epidemiol. 2013;42(1):111&#x2013;127. doi: 10.1093/ije/dys064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys064</ArticleId><ArticleId IdType="pmc">PMC3600618</ArticleId><ArticleId IdType="pubmed">22507743</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, et al. Cohort profile: the Avon longitudinal study of parents and children: ALSPAC mothers cohort. Int J Epidemiol. 2013;42(1):97&#x2013;110. doi: 10.1093/ije/dys066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys066</ArticleId><ArticleId IdType="pmc">PMC3600619</ArticleId><ArticleId IdType="pubmed">22507742</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdi S, Abbasian G, Bowyer RCE, Lachance G, Yarand D, Christofidou P, et al. TwinsUK: the UK adult twin registry update. Twin Res Hum Genet. 2019;22(6):523&#x2013;529. doi: 10.1017/thg.2019.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/thg.2019.65</ArticleId><ArticleId IdType="pubmed">31526404</ArticleId></ArticleIdList></Reference><Reference><Citation>Suthahar A, Sharma P, Hart D, Garc&#xed;a M, Horsfall R, Bowyer R, et al. TwinsUK COVID-19 personal experience questionnaire (CoPE): wave 1 data capture april-may 2020 [version 1; peer review: awaiting peer review] Wellcome Open Res. 2021;6:123. doi: 10.12688/wellcomeopenres.16671.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16671.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Small N, Raynor P, Tuffnell D, Bhopal R, Cameron N, et al. Cohort profile: the born in Bradford multi-ethnic family cohort study. Int J Epidemiol. 2013;42(4):978&#x2013;991. doi: 10.1093/ije/dys112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys112</ArticleId><ArticleId IdType="pubmed">23064411</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson J, Bird PK, McEachan RRC, Pickett KE, Waiblinger D, Uphoff E, et al. Born in Bradford&#x2019;s better start: an experimental birth cohort study to evaluate the impact of early life interventions. BMC Public Health. 2016;16(1):711. doi: 10.1186/s12889-016-3318-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-016-3318-0</ArticleId><ArticleId IdType="pmc">PMC4996273</ArticleId><ArticleId IdType="pubmed">27488369</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck N, McFall S. Understanding society: design overview. Longitud Life Course Stud. 2012;3(1):5&#x2013;17.</Citation></Reference><Reference><Citation>University of Essex, Institute for Social and Economic Research. Understanding Society: COVID-19 Study, 2020&#x2013;2021. [data collection]. 11th Edition. UK Data Service. SN: 8644. 2021.</Citation></Reference><Reference><Citation>Smith BH, Campbell A, Linksted P, Fitzpatrick B, Jackson C, Kerr SM, et al. Cohort profile: generation Scotland: Scottish family health study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int J Epidemiol. 2013;42(3):689&#x2013;700. doi: 10.1093/ije/dys084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys084</ArticleId><ArticleId IdType="pubmed">22786799</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawns-Ritchie C, Altschul D, Campbell A, Huggins C, Nangle C, Dawson R, et al. CovidLife: a resource to understand mental health, well-being and behaviour during the COVID-19 pandemic in the UK [version 1; peer review: 1 approved] Wellcome Open Res. 2021;6:176. doi: 10.12688/wellcomeopenres.16987.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16987.1</ArticleId><ArticleId IdType="pmc">PMC10884595</ArticleId><ArticleId IdType="pubmed">38406227</ArticleId></ArticleIdList></Reference><Reference><Citation>Nylund KL, Asparouhov T, Muth&#xe9;n BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a monte carlo simulation study. Struct Equ Model Multidiscip J. 2007;14(4):535&#x2013;569. doi: 10.1080/10705510701575396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10705510701575396</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Wan H, Yuan H, Zhou L, Xiao C, Mao S, et al. Symptom clustering patterns and population characteristics of COVID-19 based on text clustering method. Front Public Health. 2022;10:795734. doi: 10.3389/fpubh.2022.795734.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.795734</ArticleId><ArticleId IdType="pmc">PMC8854172</ArticleId><ArticleId IdType="pubmed">35186839</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre Carole H, Lee Karla A, Ni Lochlainn M, Varsavsky T, Murray B, Graham Mark S, et al. Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app. Sci Adv. 2021;7(12):eabd4177. doi: 10.1126/sciadv.abd4177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd4177</ArticleId><ArticleId IdType="pmc">PMC7978420</ArticleId><ArticleId IdType="pubmed">33741586</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra N, Chowdhury M, Singh AK, Ma K, Kumar A, Ranjan P, et al. Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov Ther. 2021;15(3):156&#x2013;161. doi: 10.5582/ddt.2021.01014.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2021.01014</ArticleId><ArticleId IdType="pubmed">34234065</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect Dis. 2022;9(2):ofab640. doi: 10.1093/ofid/ofab640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab640</ArticleId><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;92(10):1902&#x2013;1914. doi: 10.1002/jmv.25884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25884</ArticleId><ArticleId IdType="pmc">PMC7262119</ArticleId><ArticleId IdType="pubmed">32293716</ArticleId></ArticleIdList></Reference><Reference><Citation>Olumade TJ, Uzairue LI. Clinical characteristics of 4499 COVID-19 patients in Africa: a meta-analysis. J Med Virol. 2021;93(5):3055&#x2013;3061. doi: 10.1002/jmv.26848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26848</ArticleId><ArticleId IdType="pmc">PMC8013423</ArticleId><ArticleId IdType="pubmed">33543800</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID study. Lancet. 2022;399(10335):1618&#x2013;1624. doi: 10.1016/S0140-6736(22)00327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>